Healthcare | December 08, 2025
Bengaluru healthtech firm Biomoneta secures USFDA nod for air purifier
Captured microbes are then neutralized on engineered microbicidal surfaces
Captured microbes are then neutralized on engineered microbicidal surfaces
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
Jacobio stated that these findings underscore the potential of glecirasib and sitneprotafib
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
The PCR-based test, delivered via Roche’s cobas liat system, allows results to be obtained during a patient consultation in GP practices and Emergency Rooms
This inspection was conducted following the warning letter issued by the USFDA
Suffering from acute migraine? You may soon bid adieu to the debilitating headache
Seeing well-controlled Phase 3 data that shows a marked slowing of lesion growth in Stargardt disease is deeply encouraging
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
